Tatva Chintan Pharma Chem Ltd

Tatva Chintan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tatva Chintan Pharma Chem Ltd

₹ 1,244 1.27%
03 May - close price
tatvachintan.com BSE: 543321 NSE : TATVA
About

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals[1]

Key Points

Leading Chemical Manufacturer[1]
It is the largest manufacturer of Structure Directing Agents (SDA) for Zeolites in India.

Website BSE NSE
  • Market Cap ₹ 2,909 Cr.
  • Current Price ₹ 1,244
  • High / Low ₹ 1,888 / 1,061
  • Stock P/E 99.1
  • Book Value ₹ 310
  • Dividend Yield 0.16 %
  • ROCE 6.89 %
  • ROE 4.77 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 4.01 times its book value
  • Company has a low return on equity of 11.9% over last 3 years.
  • Dividend payout has been low at 10.5% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
104.50 107.65 116.69 101.59 101.88 86.07 84.04 113.54 119.41 106.11 92.57 86.07 93.93
80.46 80.90 82.46 78.83 79.78 72.58 75.11 96.69 104.00 86.50 71.84 73.75 79.73
Operating Profit 24.04 26.75 34.23 22.76 22.10 13.49 8.93 16.85 15.41 19.61 20.73 12.32 14.20
OPM % 23.00% 24.85% 29.33% 22.40% 21.69% 15.67% 10.63% 14.84% 12.91% 18.48% 22.39% 14.31% 15.12%
2.01 1.57 2.60 5.08 1.19 1.88 1.95 1.07 -2.81 1.02 0.76 1.21 4.53
Interest 1.05 1.44 1.22 0.99 1.18 1.06 1.76 2.38 3.18 2.90 3.01 0.38 0.22
Depreciation 1.78 1.90 2.06 2.08 2.15 2.33 2.31 2.38 2.53 6.01 6.78 6.58 6.23
Profit before tax 23.22 24.98 33.55 24.77 19.96 11.98 6.81 13.16 6.89 11.72 11.70 6.57 12.28
Tax % 12.40% 4.08% 8.44% 9.49% 5.41% 28.96% 22.91% 19.76% -134.40% 29.61% 30.00% 29.07% 32.82%
20.35 23.96 30.72 22.43 18.89 8.50 5.26 10.56 16.15 8.25 8.20 4.65 8.25
EPS in Rs 10.13 11.93 13.86 10.12 8.52 3.83 2.37 4.76 7.29 3.72 3.51 1.99 3.53
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
131 203 254 291 428 403 379
110 170 201 226 322 348 312
Operating Profit 22 33 53 65 106 55 67
OPM % 16% 16% 21% 22% 25% 14% 18%
2 1 1 5 11 2 8
Interest 3 4 4 4 5 9 7
Depreciation 3 4 5 7 8 10 26
Profit before tax 18 26 44 59 103 39 42
Tax % 38% 24% 21% 13% 7% -4% 31%
11 20 35 51 96 40 29
EPS in Rs 13.74 25.13 43.51 25.57 43.31 18.26 12.55
Dividend Payout % -0% -0% -0% 20% 5% 11% 16%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: 9%
TTM: -6%
Compounded Profit Growth
10 Years: %
5 Years: 8%
3 Years: -17%
TTM: -33%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -32%
Return on Equity
10 Years: %
5 Years: 15%
3 Years: 12%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 8 8 20 22 22 23
Reserves 51 72 106 142 447 483 702
56 77 91 90 120 170 14
29 31 40 58 87 80 75
Total Liabilities 145 187 245 310 676 755 815
57 67 111 120 160 196 430
CWIP 10 6 5 10 51 231 73
Investments 1 1 1 1 1 1 11
76 114 129 179 464 327 301
Total Assets 145 187 245 310 676 755 815

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
25 19 20 24 103
-40 -21 -197 -101 -121
10 -5 235 38 31
Net Cash Flow -6 -6 58 -40 13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 92 80 73 113 53 82 66
Inventory Days 134 98 165 168 299 249 313
Days Payable 132 70 88 116 82 52 96
Cash Conversion Cycle 94 109 150 166 269 278 282
Working Capital Days 105 117 103 152 164 176 176
ROCE % 22% 27% 28% 26% 8%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
79.17% 79.17% 79.17% 79.17% 79.17% 79.17% 79.17% 79.17% 72.02% 72.02% 72.02%
3.53% 2.91% 3.05% 3.53% 3.59% 3.74% 3.54% 3.19% 4.40% 4.21% 3.65%
7.36% 7.87% 8.13% 10.75% 11.17% 11.52% 11.71% 11.07% 13.78% 13.06% 12.84%
9.94% 10.05% 9.65% 6.55% 6.08% 5.58% 5.59% 6.56% 9.79% 10.72% 11.49%
No. of Shareholders 89,43888,31189,93084,35876,26771,95870,03770,79974,62874,51973,730

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls